ESCRS - Supplement: Premium IOL Solutions - Your way out of the Labyrinth ;
Supplements

Supplement: Premium IOL Solutions - Your way out of the Labyrinth

Supplement: Premium IOL Solutions - Your way out of the Labyrinth

One-stop premium IOL provider

In today's premium intraocular lens (IOL) market, the abundance of lens options and surgical techniques is overwhelming, evoking a sense of navigating through a labyrinth. A new paradigm has emerged: the art of selecting the right lens to match each patient's unique visual needs and expectations.

Medicontur has become a one-stop premium IOL provider for leading clinics around the world. This supplement showcases Medicontur's premium lead technologies and clinical insights by leading experts in the field of refractive surgery, showing a way out of this labyrinth.

Latest Articles
ESCRS Research Projects Make a Difference

EPICAT study continues tradition of practice-changing clinical studies.

Read more...

Tablao Debates: Cataract-Refractive Edition

Lively debate format pairs EDOF lenses with trifocals in a dance for first prize in surgery choice.

Read more...

Phakic IOLs for Myopia and Presbyopia

Many options for patients under age 60.

Read more...

Effect of COVID-19 and Vaccine on Retinal Disease

Registry-based studies indicate risk for retinal vascular occlusions have not increased.

Read more...

ESCRS Accepting Applications for Peter Barry Fellowship

Read more...

Setting Limits for PRK and LASIK

Clinical evaluation and personal judgment come into play.

Read more...

Advances in Adaptive Optics

New tools allow better preoperative prediction and greater customisation.

Read more...

Real-World Strategies for New Tech Adoption

Step by step real-world experience shows improvement in clinical outcomes.

Read more...

Going Beyond Cataract Camps

ESCRS expanding treatment opportunities in underserved areas.

Read more...

Bridging the Gap Between Local and Global

New training programmes seek to reach hard-to-reach areas to meet growing patient needs.

Read more...